Actively Recruiting
Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation
Led by Bedaya Hospital · Updated on 2026-05-04
120
Participants Needed
2
Research Sites
168 weeks
Total Duration
On this page
Sponsors
B
Bedaya Hospital
Lead Sponsor
C
Cairo University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this randomized controlled trial is to compare the efficacy and cost-effectiveness of using progestin with GnRH antagonist to prevent premature LH surge in poor responders undergoing double stimulation protocol.
CONDITIONS
Official Title
Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients aged 35 to 44 years
- Patients classified as poor responders belonging to Poseidon group 4
You will not qualify if you...
- Diagnosis of polycystic ovary syndrome (PCOS)
- Diagnosis of endometriosis
- History of recurrent abortion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Cairo University
Cairo, Cairo Governorate, Egypt
Actively Recruiting
2
Bedaya Hospital
Giza, Egypt
Not Yet Recruiting
Research Team
U
Usama M Fouda, Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here